US Physical Therapy | 10-Q: Quarterly report
U.S. Physical Therapy Down Over 6%, on Pace for Largest Percent Decrease in Over a Year -- Data Talk
U.S. Physical Therapy Declares $0.44 Dividend
BofA Securities Maintains US Physical Therapy(USPH.US) With Buy Rating, Cuts Target Price to $114
Express News | US Physical Therapy Inc : BofA Global Research Cuts Price Objective to $114 From $121
Maintaining 'Buy' Rating on US Physical Therapy Amid Cost Pressures and Revenue Growth
US Physical Therapy To Go Ex-Dividend On August 23rd, 2024 With 0.44 USD Dividend Per Share
U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates
US Physical Therapy Shares Fall 4% on Q2 Earnings Miss, Lowered Guidance
U.S. Physical Therapy GAAP EPS of $0.47 Misses by $0.36, Revenue of $167.19M Beats by $3.9M
Express News | U.S. Physical Therapy Returned Its Guidance For Adjusted EBITDA For 2024 To Its Original Range Of $80M-$85M
Earnings Flash (USPH) U.S. PHYSICAL THERAPY Posts Q2 Revenue $167.2M, Vs. Street Est of $163.3M
Express News | US Physical Therapy Q2 Net Income USD 7.5 Million
Express News | US Physical Therapy Q2 Dividend USD 0.44
Express News | US Physical Therapy Outlook FY Adjusted Ebitda USD 80-85 Million
Express News | US Physical Therapy Q2 Adjusted Ebitda USD 22.1 Million Vs. IBES Estimate USD 23.6 Million
Express News | US Physical Therapy Q2 EPS USD 0.47 Vs. IBES Estimate USD 0.82
U.S. Physical Therapy Reports Second Quarter 2024 Results
At US$91.00, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?
Should You Be Confident in U.S. Physical Therapy (USPH)?